Should Cardiac Troponins be Used as a Risk Stratification Tool for Patients with Chronic Critical Limb Ischaemia?  by Sarveswaran, J. et al.
JOURNAL OF VASCULAR SURGERY
Volume 45, Number 6 Abstracts 1289Should Cardiac Troponins be Used as a Risk Stratification Tool for
Patients with Chronic Critical Limb Ischaemia?
Sarveswaran J., Ikponmwosa A., Asthana S., Spark J.I. Eur J Vasc Endovasc
Surg 2007;33:703-707.
Objectives Cardiovascular mortality in patients with chronic critical
lower limb ischaemia (CCLI) is high and early risk stratification in these
patients may aid clinical management improving outcomes. Cardiac tropo-
nin I (cTnI) has prognostic significance in patients with unstable angina. The
aim of this study was to evaluate the prognostic significance of cardiac
troponins in CCLI patients who had no clinical evidence of unstable
coronary heart disease.
Methods Patients (n152) admitted with CCLI to a single vascular
unit over a two-year period were included prospectively in this study.
Patients with clinical evidence of unstable coronary disease were excluded
from the study. Patient demographics, clinical history, co-morbidity and risk
factors for peripheral vascular disease were documented. Admission cTnI
levels were recorded using a threshold, 0.1 ng/ml. The primary endpoint
was mortality.
Results Fifty-two patients (34.2%) had an elevated cTnI, whilst 100
(65.8%) had cTnI 0.1 ng/ml. Sixty-two patients died during the
follow-up period, 38 with an elevated admission cTnI. Death rate in patients
with cTnI 0.1 ng/nl was 73% compared with 24% in those with levels
below the threshold (p0.0001). Patients with elevated cTnI were signifi-
cantly older than those with normal level (median age 76 years vs 71 years,
p0.001). An elevated cTnI was found to independently predict disease-
specific mortality on Cox regression analysis (Hazard Ratio 4.2; 95% Con-
fidence Interval 1.3–12.7).
Conclusion In this series of patients with CCLI the measurement of
cTnI on admission was a significant independent predictor of survival. cTnI
has potential as a prognostic test to stratify patients with a high cardiovas-
cular risk and may enable further optimisation of these high-risk patients.
Late Outcome of Spinal Cord Stimulation for Unreconstructable and
Limb-threatening Lower Limb Ischemia
Gersbach P.A., Argitis V., Gardaz J.-P., von Segesser L.K., Haesler E. Eur J
Vasc Endovasc Surg 2007;33:717-24.
Objectives To determine whether the initial benefits of spinal cord
stimulation (SCS) treatment for critical limb ischemia (CLI) persist over
years.
Design Analysis of data prospectively collected for every CLI patient
receiving permanent SCS. Follow-up range 12 to 98 months (mean 4623,
median 50 months).
Population 87 patients (28% stage III, 72%stage IV) with unrecon-Readers can access EJVES articles at http://intl.eMethods Assessment of actuarial patient survival (PS), limb salvage
(LS) and amputation-free patient survival (AFPS). Analysis of the impact of
15 risk factors on long-term outcomes using the Fischer’s exact test for
categorical variables and the t test for continuous variables.
Results Follow-up was complete for patient and limb survival. A single
non-atherosclerotic patient died during follow-up. Among atherosclerotic
patients PS decreased from 88% at 1y, to 76% at 3y, 64% at 5y and 57% at 7y.
LS reached 84% at 1y, 78% at 2y, 75% at 3y and remained stable thereafter.
Diabetes was found to affect LS (p0.05) and heart disease to reduce PS
(p0.01). AFPS was reduced in heart patients (p0.01), diabetics
(p0.05) and in patients with previous stroke (p0.05).
Conclusions In CLI patients the beneficial effects of SCS persist far
beyond the first year of treatment andmajor amputation becomes infrequent
after the second year.
The Predictive Value ofHaemodynamic Assessment in Chronic Venous
Leg Ulceration
Gohel M.S., Barwell J.R., Heather B.P., Earnshaw J.J., Mitchell D.C.,
Whyman M.R., Poskitt K.R. Eur J Vasc Endovasc Surg 2007;33:742-46.
Objectives The aim of this study was to assess the value of PPG in
predicting healing and recurrence in patients with chronic venous ulcer-
ation.
Methods 500 patients with open or recently healed venous ulceration
were treated with either multilayer compression or compression plus super-
ficial venous surgery and followed up in specialist clinics as part of a clinical
study. At initial assessment, VRT was measured using PPGwith and without
a below-knee tourniquet inflated to 80 mmHg to occlude superficial veins.
Legs were stratified into groups with VRT 11 s, 11–20 s and 20 s and
comparison of healing and recurrence rates between these groups was
performed.
ResultsVRTmeasurements were not achieved in 117 patients, primar-
ily due to ankle stiffness. Of the remaining 383 patients, VRT without
tourniquet did not correlate with ulcer healing (p0.26, 0.40) or recurrence
(p0.20, 0.79, Log rank test) for legs treated with compression or compres-
sion plus surgery respectively. However, VRT readings taken with a below-
knee tourniquet were predictive of ulcer healing (p0.01) and recurrence
(p0.05, Log-rank test). The correlation was greatest for healing in legs
treated with compression alone, where 24 week healing rates were 62%, 73%
and 92% for legs with VRTs with tourniquet 11 s, 11–20 s and 20 s
respectively (p0.01, Log rank test). For legs treated with surgery, 1 year
recurrence rates were 24%, 10% and 3% for groups with VRTs with tourni-
quet 11 s, 11–20 s and 20 s respectively (p0.03, Log rank test).
Conclusions Digital PPG assessment may predict ulcer healing and
recurrence, but only by using a below-knee tourniquet. This informationstructable CLI due (83%) or not (17%) to atherosclerosis and with an initial
sitting/supine transcutaneous pO2 gradient 15 mmHg.
could aid the selection of patients with venous ulceration most likely to
benefit from superficial venous surgery.lsevierhealth.com/journals/ejvs/default.cfm
